Comparison

MD1 Antibody (C-term) Blocking Peptide

Item no. ABC-BP2544b
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Lyophilized
Specific against other
Citations Begum, N.A., et al., Biochem. Biophys. Res. Commun. 256(2):325-329 (1999).Miura, Y., et al., Blood 92(8):2815-2822 (1998).Miyake, K., et al., J. Immunol. 161(3):1348-1353 (1998).
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Lymphocyte antigen 86,Ly-86,Protein MD-1,LY86,MD1
Similar products LY86, MD1, Lymphocyte antigen 86, Protein MD-1, Ly-86
Available
Manufacturer - Category
Peptides; Blocking Peptides
Manufacturer - Targets
The synthetic peptide sequence used to generate the antibody AP2544b was selected from the C-term region of human MD1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Bio Background
MD1 may cooperate with CD180 and TLR4 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) and cytokine production. This protein is important for efficient CD180 cell surface expression. MD1 is highly expressed in B-cells, monocytes and tonsil. In monocytes, it is down-regulated by the cell-wall fraction of Mycobacterium bovis.
Gene Name
LY86
Subtitle
Synthetic peptide
Formulation
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close